These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 23643507)

  • 41. Comparison of two commercial molecular assays to a laboratory-developed molecular assay for diagnosis of Clostridium difficile infection.
    Karre T; Sloan L; Patel R; Mandrekar J; Rosenblatt J
    J Clin Microbiol; 2011 Feb; 49(2):725-7. PubMed ID: 21123537
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnostic trends in Clostridium difficile detection in Finnish microbiology laboratories.
    Könönen E; Rasinperä M; Virolainen A; Mentula S; Lyytikäinen O
    Anaerobe; 2009 Dec; 15(6):261-5. PubMed ID: 19591954
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of a rapid molecular method, the BD GeneOhm Cdiff assay, to the most frequently used laboratory tests for detection of toxin-producing Clostridium difficile in diarrheal feces.
    Terhes G; Urbán E; Sóki J; Nacsa E; Nagy E
    J Clin Microbiol; 2009 Nov; 47(11):3478-81. PubMed ID: 19794052
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of a new automated homogeneous PCR assay, GenomEra C. difficile, for rapid detection of Toxigenic Clostridium difficile in fecal specimens.
    Hirvonen JJ; Mentula S; Kaukoranta SS
    J Clin Microbiol; 2013 Sep; 51(9):2908-12. PubMed ID: 23804386
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection of Clostridium difficile toxins in stools. Comparison between a new enzyme immunoassay for toxin A and other routine tests.
    Depitre C; Avesani V; Delmée M; Corthier G
    Gastroenterol Clin Biol; 1993; 17(4):283-6. PubMed ID: 8339887
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk factors for Clostridium difficile-associated diarrhea among hospitalized adults with fecal toxigenic C. difficile colonization.
    Lin HJ; Hung YP; Liu HC; Lee JC; Lee CI; Wu YH; Tsai PJ; Ko WC
    J Microbiol Immunol Infect; 2015 Apr; 48(2):183-9. PubMed ID: 24064285
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multiplex PCR targeting tpi (triose phosphate isomerase), tcdA (Toxin A), and tcdB (Toxin B) genes for toxigenic culture of Clostridium difficile.
    Lemee L; Dhalluin A; Testelin S; Mattrat MA; Maillard K; Lemeland JF; Pons JL
    J Clin Microbiol; 2004 Dec; 42(12):5710-4. PubMed ID: 15583303
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of a nucleic acid amplification assay for the diagnosis of Clostridioides difficile infection.
    Koyuncu-Ozyurt O; Ozhak B; Ogunc D; Ongut G; Gunseren F; Donmez L; Colak D
    Anaerobe; 2019 Oct; 59():201-204. PubMed ID: 31255716
    [TBL] [Abstract][Full Text] [Related]  

  • 49. "Second-look" cytotoxicity: an evaluation of culture plus cytotoxin assay of Clostridium difficile isolates in the laboratory diagnosis of CDAD.
    Bouza E; Peláez T; Alonso R; Catalán P; Muñoz P; Créixems MR
    J Hosp Infect; 2001 Jul; 48(3):233-7. PubMed ID: 11439012
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical comparison of Simplexa universal direct and BD GeneOhm tests for detection of toxigenic Clostridium difficile in stool samples.
    Nolte FS; Ribeiro-Nesbitt DG
    J Clin Microbiol; 2014 Jan; 52(1):281-2. PubMed ID: 24197886
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of the cobas 4800 system for the rapid detection of toxigenic Clostridium difficile and methicillin-resistant Staphylococcus aureus.
    Moure R; Cañizares Á; Muíño M; Lobato M; Fernández A; Rodríguez M; Gude MJ; Tomás M; Bou G
    J Microbiol Methods; 2016 Jan; 120():50-2. PubMed ID: 26611812
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection of toxigenic Clostridium difficile: comparison of the cell culture neutralization, Xpert C. difficile, Xpert C. difficile/Epi, and Illumigene C. difficile assays.
    Pancholi P; Kelly C; Raczkowski M; Balada-Llasat JM
    J Clin Microbiol; 2012 Apr; 50(4):1331-5. PubMed ID: 22278839
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of the Liat Cdiff Assay for Direct Detection of Clostridioides difficile Toxin Genes within 20 Minutes.
    Hetem DJ; Bos-Sanders I; Nijhuis RHT; Tamminga S; Berlinger L; Kuijper EJ; Sickler JJ; Claas ECJ
    J Clin Microbiol; 2019 Jun; 57(6):. PubMed ID: 30944191
    [No Abstract]   [Full Text] [Related]  

  • 54. Evaluation of the Cepheid Xpert C. difficile/Epi and meridian bioscience illumigene C. difficile assays for detecting Clostridium difficile ribotype 033 strains.
    Androga GO; McGovern AM; Elliott B; Chang BJ; Perkins TT; Foster NF; Riley TV
    J Clin Microbiol; 2015 Mar; 53(3):973-5. PubMed ID: 25520452
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of toxigenic Clostridium difficile in diarrheal stools by rapid real-time polymerase chain reaction.
    Goldenberg SD; Dieringer T; French GL
    Diagn Microbiol Infect Dis; 2010 Jul; 67(3):304-7. PubMed ID: 20542211
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection of toxigenic Clostridium difficile in stool samples by real-time polymerase chain reaction for the diagnosis of C. difficile-associated diarrhea.
    Peterson LR; Manson RU; Paule SM; Hacek DM; Robicsek A; Thomson RB; Kaul KL
    Clin Infect Dis; 2007 Nov; 45(9):1152-60. PubMed ID: 17918076
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detection of Clostridium difficile toxin A and B genes from stool samples of Thai diarrheal patients by polymerase chain reaction technique.
    Wongwanich S; Rugdeekha S; Pongpech P; Dhiraputra C
    J Med Assoc Thai; 2003 Oct; 86(10):970-5. PubMed ID: 14650710
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of antigen and two molecular methods for the detection of Clostridium difficile toxins.
    Ylisiurua P; Koskela M; Vainio O; Tuokko H
    Scand J Infect Dis; 2013 Jan; 45(1):19-25. PubMed ID: 22998479
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of two commercial molecular tests for the detection of Clostridium difficile in the routine diagnostic laboratory.
    Zidarič V; Kotnik Kevorkijan B; Oresic N; Janezic S; Rupnik M
    J Med Microbiol; 2011 Aug; 60(Pt 8):1131-1136. PubMed ID: 21372187
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Trends and changes in Clostridium difficile diagnostic policies and their impact on the proportion of positive samples: a national survey.
    Adler A; Schwartzberg Y; Samra Z; Schwartz O; Carmeli Y; Schwaber MJ;
    Clin Microbiol Infect; 2014 Nov; 20(11):O904-10. PubMed ID: 24674056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.